Clinical cancer research: The past, present and the future

Vincent T. Devita, Alexander M.M. Eggermont, Samuel Hellman, David J. Kerr

Onderzoeksoutput: Bijdrage aan tijdschriftArtikel recenserenpeer review

29 Citaten (Scopus)

Samenvatting

In the past decade, we have witnessed unprecedented changes and some remarkable advances that have enabled true personalized medicine. Nevertheless, many challenges in clinical cancer research remain and need to be overcome if we are to witness similar progress in the next decade. Such hurdles include, but are not limited to, clinical development and testing of multiple agents in combination, design of clinical trials to best accommodate the ever increasing knowledge of heterogeneity of the disease, regulatory challenges relating to drug development and trial design, and funding for basic research. With this in mind, we asked four leading cancer researchers from around the world, and who have been associated with the journal since its launch in November 2004 what, in their opinion, we have learnt over the past 10 years and how we should progress in the next 10 years.

Originele taal-2Engels
Pagina's (van-tot)663-669
Aantal pagina's7
TijdschriftNature reviews. Clinical oncology
Volume11
Nummer van het tijdschrift11
DOI's
StatusGepubliceerd - 5 nov. 2014
Extern gepubliceerdJa

Vingerafdruk

Duik in de onderzoeksthema's van 'Clinical cancer research: The past, present and the future'. Samen vormen ze een unieke vingerafdruk.

Citeer dit